Weekly Cosmetic Research Analysis
This week’s cosmetic-related literature emphasizes function-focused reconstruction, novel biologic delivery for aesthetic indications, and evidence-based guidance for diagnosis of cosmetically sensitive skin malignancy. A prospective dynamic abdominal wall reconstruction for Prune Belly Syndrome demonstrates objective functional reanimation; recombinant Filaggrin‑2 delivered by microneedles shows preclinical reversal of androgenetic alopecia; and an international consensus refines diagnostic and
Summary
This week’s cosmetic-related literature emphasizes function-focused reconstruction, novel biologic delivery for aesthetic indications, and evidence-based guidance for diagnosis of cosmetically sensitive skin malignancy. A prospective dynamic abdominal wall reconstruction for Prune Belly Syndrome demonstrates objective functional reanimation; recombinant Filaggrin‑2 delivered by microneedles shows preclinical reversal of androgenetic alopecia; and an international consensus refines diagnostic and management pathways for lentigo maligna on cosmetically important sites.
Selected Articles
1. Functional Reconstruction of Abdominal Wall in Prune Belly Syndrome Using Vastus Lateralis Muscle Flaps: A Prospective Observational Study.
A prospective series describes bilateral pedicled, innervated vastus lateralis musculo‑fascial flap transfers to recreate rectus abdominis vectors in Prune Belly Syndrome. Objective EMG and motor testing confirmed active contraction, improved core function, and reduced symptoms linked to inadequate intra‑abdominal pressure (eg, constipation, respiratory infections).
Impact: Presents the first reproducible dynamic reanimation of the anterior abdominal wall in a rare congenital disorder with objective functional endpoints, shifting reconstructive goals from contour to physiology.
Clinical Implications: Provides a function‑first surgical option for PBS that may restore cough, defecation, and postural control; adoption will require multidisciplinary planning, attention to donor‑site morbidity, and standardized rehabilitation protocols.
Key Findings
- Bilateral pedicled, innervated vastus lateralis flaps recreated rectus abdominis functional vectors enabling dynamic contraction.
- EMG and motor testing confirmed active muscle contraction with improved core function.
- Patients experienced reductions in symptoms related to low intra‑abdominal pressure (eg, constipation, respiratory infections).
2. Recombinant Filaggrin-2 microneedles reverse androgenetic alopecia by rescuing mitochondrial dysfunction in dermal papilla cells.
Preclinical work identifies DHT-driven downregulation of Filaggrin‑2 in dermal papilla cells and demonstrates that recombinant FLG2 delivered via hyaluronic acid microneedles rescues DPC viability, mitochondrial function (MAPK/Erk and Bcl‑2/Bax pathways), prolongs anagen, and increases follicle density in a mouse AGA model.
Impact: Identifies FLG2 as a novel, mechanism‑based target for androgenetic alopecia and demonstrates a minimally invasive topical biologic delivery with in vivo efficacy, advancing translational potential beyond small‑molecule approaches.
Clinical Implications: If safety and immunogenicity are favorable in humans, rFLG2 microneedles could become a topical, targeted therapy for AGA that addresses mitochondrial dysfunction in dermal papilla cells; next steps are dose‑finding and early human trials.
Key Findings
- DHT downregulates FLG2 in dermal papilla cells, contributing to AGA pathogenesis.
- rFLG2@HA/MNs rescued DPC viability, migration, adhesion via MAPK/Erk activation and Bcl‑2/Bax rebalancing.
- In AGA mouse models, rFLG2@HA/MNs increased follicle density and prolonged anagen; also accelerated wound healing in full‑thickness defects.
3. International Dermoscopy Society consensus recommendations for the management of lentigo maligna.
An international, multidisciplinary consensus synthesizes evidence to provide practical recommendations for diagnosing, treating, and monitoring lentigo maligna on cosmetically sensitive skin. Recommendations emphasize dermoscopy and reflectance confocal microscopy for mapping, multiple partial biopsies, margin‑controlled excision when feasible, and topical imiquimod or radiotherapy when surgery is unsuitable, with structured imaging follow‑up.
Impact: Bridges a limited and heterogeneous evidence base to produce actionable, practice‑oriented recommendations for a diagnostically challenging lesion on cosmetically important sites, likely to harmonize care and reduce variability.
Clinical Implications: Clinicians should integrate dermoscopy and RCM for lesion mapping and biopsy planning, prefer margin‑controlled excision for ill‑defined lesions, and use topical/radiation alternatives with close imaging follow‑up when surgery is not possible.
Key Findings
- Non‑invasive imaging (dermoscopy and RCM) improves diagnosis, biopsy orientation, and monitoring.
- Multiple partial biopsies increase diagnostic certainty and help exclude invasion.
- Margin‑controlled excision is preferred for large or poorly defined lesions; imiquimod or radiotherapy are alternatives when surgery is unsuitable.